Unexplained weight loss (UWL), defined as a loss of 5% body weight over a period of 6 to 12 months without a clear etiology, presents a significant diagnostic challenge in clinical practice. Its differential diagnosis is vast, ranging from malignancies to psychiatric disorders, making a comprehensive approach imperative for effective patient management.
Firstly, a thorough history and physical examination is crucial, focusing on dietary changes, gastrointestinal symptoms, and systemic signs. Consideration should also be given to medications and their potential side effects. If initial investigations are unrevealing, broad-spectrum laboratory tests including complete blood count, metabolic panel, thyroid function tests, and inflammatory markers should be conducted.
If no diagnosis is reached after the above steps, imaging studies may be warranted. Abdominal ultrasound or CT scan can reveal malignancies or chronic diseases. Endoscopy or colonoscopy should be considered for persistent gastrointestinal symptoms. Specialized tests like HIV testing or tuberculosis screening may be considered based on epidemiological risk factors.
Psychiatric illnesses, particularly depression and eating disorders, can often manifest as UWL. A careful psychosocial history, ideally with the input of a mental health professional, is thus essential. Additionally, social determinants of health, such as food insecurity, should not be overlooked.
For patients with UWL where no cause is found, a watchful waiting approach may be appropriate. Regular follow-ups and monitoring for the emergence of new symptoms can guide further investigations and management.
In conclusion, a meticulous, step-wise approach to UWL can help clinicians navigate the diagnostic complexities and ensure optimal patient care. The process not only involves a comprehensive medical examination but also considers psychosocial factors, emphasizing the importance of holistic care in clinical practice.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation